Clinical Trials Directory

Trials / Completed

CompletedNCT01402128

Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects

The Effect of Barley Beta-glucan on Serum Lipids and Body Weight

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Accepted

Summary

Barley, like oats, is a rich source of the soluble fibre β-glucan, which has been shown to significantly lower LDL-cholesterol (LDL-C). However, barley foods have been less widely studied.

Detailed description

This study investigated whether the supplementation of barley β-glucan is reduce the visceral fat as well as the serum low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in mildly hypercholesterolemic subjects. In a 12 week double-blind, controlled study, subjects were randomized to one of treatment group(3.0g/day as β-glucan) or placebo group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBarley beta-glucan(3.0g)Barley beta-glucan(3.0g/day) for 12 weeks
DIETARY_SUPPLEMENTPlaceboPlacebo for 12 weeks

Timeline

Start date
2010-06-01
Primary completion
2010-10-01
Completion
2011-05-01
First posted
2011-07-26
Last updated
2012-12-25
Results posted
2012-12-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01402128. Inclusion in this directory is not an endorsement.